Skip to content

Study on effects of Luffa cylindrica intake by different cooking methods on blood pressure

Study on effects of Luffa cylindrica intake by different cooking methods on blood pressure - Effects of Luffa cylindrica intake on blood pressure

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000038270
Enrollment
180
Registered
2019-10-11
Start date
2019-10-12
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Subjects with high normal blood pressure or grade 1 hypertension

Interventions

Intake of 200mL Luffa smoothie made by steaming (everyday for 12 weeks) Intake of 200mL Luffa smoothie made by boiling (everyday for 12 weeks) intake of 200mL placebo smoothie (everyday for 12 weeks)

Sponsors

Unicersity of the Ryukyus
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1) Subjects with BMI above 20 kg/m2-under 30 kg/m2 2) Subjects with high normal blood pressure (Systolic BP from 130 to 139 mmHg and/or diastolic blood pressure from 85-89 mmHg) or grade1 hypertension (Systolic BP from 140 to 159 mmHg and/or diastolic blood pressure from 90-99 mmHg) 3) Subjects who can receive sufficient explanation, understand the contents, and hand in written consent by the person

Exclusion criteria

Exclusion criteria: 1) Subjects who regularly consume medicines, food for specified health use, health food, etc. that may affect the test results. 2) Subjects who are currently on a diet or are planning a diet. 3) Subjects who plan to travel for a long time during the examination period. 4) Alcoholic drinkers (Alcohol intake 60 g / day or more). 5) Subjects who have irregular diets, irregular shift rhythms, shift workers, late-night workers. 6) Subjects who have a history of serious diseases such as heart, liver, kidney, digestive system etc. 7) Subjects who are pregnant, planning pregnancy or nursing. 8) Subjects who are participating in clinical trials of other medicines or health food, within 4 weeks after the end of the trial, or who are planning to participate in other clinical trials after consenting to participate in the trial. 9) Subjects who are continuing treatment with drugs. 10) Subjects who are allergic to medicines or food (especially Luffa). 11) Subjects who performed component blood donation or blood donation of 200mL of whole blood from the month before the start of the trial. 12) Men who performed blood donation of 400mL whole blood three months before the start of the trail. 13) Women who performed blood donation of 400mL whole blood four months before the start of the trial. 14) Subjects who was judged by the study principal physician or the trial division physician to be inappropriate to participate in this trial.

Design outcomes

Primary

MeasureTime frame
homoe blood pressure (Systolic blood pressure and Diatolic blood pressure)

Secondary

MeasureTime frame
blood pressure, heart rate, body weight, urinary sodium and pottasium, defecation status

Countries

Japan

Contacts

Public ContactHidemi Todoriki

University of the Ryukyus Tropical Biosphere Research Center

todoriki@comb.u-ryukyu.ac.jp098-895-8549

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026